SEC Filing · DEFA14A
Lantheus Holdings, Inc.
LNTHNASDAQEQUITYCurrent
SEC Filing
Company context
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Switzerland, Sweden and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Current securities
As-filed source
As filedOpen full document ↗